标题：Patient Characteristics and Product Use Behaviors Among Persons with E-cigarette, or Vaping, Product Use–Associated Lung Injury — Indiana, June ̶ October 2019
摘要：What is already known about this topic? As of December 4, 2019, 2,291 U.S. persons have been hospitalized with cases of e-cigarette, or vaping, product use–associated lung injury (EVALI). Among those with available data, 80% reported using products containing tetrahydrocannabinol (THC). What is added by this report? During August 8–October 28, 2019, 97 patients in Indiana were hospitalized with confirmed or probable cases of EVALI. Interviews were completed for 29 patients; among these, 69% reported using THC-containing products. What are the implications for public health practice? The percentage of Indiana EVALI patients reporting THC use was low compared with that reported for all U.S. EVALI patients. This might be due to underreporting of THC use but could also suggest that EVALI is not exclusively associated with THC use.
